tantalum

Small moleculeexperimental

Clinical trial activity

1 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0

Earliest trial started Jun 1, 2011 (NCT01420718)

Timeline

2010s

  1. Jan 1, 2011

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • tantalum
  • tantalum oxide
  • tantalum oxide
  • tantalum oxide
  • tantalum oxide (ta2o3)
  • tantalum oxide (ta2o5)
  • tantalum oxide (tao)
  • tantalum oxide (tao2)
  • tantalumpentoxide
  • tantalum pentoxide

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01420718Phase 2/Phase 3 (Phase 3)Jun 1, 2011Azad University
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Azad UniversityAcademic/Hospital1112011
1 organizations
Page 1 / 1